Patient Rating:

No Rating Available?

Marcus M. Monroe, M.D.

Patient Rating:

No Rating Available?

Clinical Details

Schedule An Appointment Clinical Office Address
(801) 587-4566 Huntsman Cancer Hospital
Clinic 1A, Head & Neck
1950 Circle of Hope
Salt Lake City, UT 84112
Map

Bio

Marcus Monroe, M.D., is an assistant professor in the Division of Otolaryngology—Head and Neck Surgery, Department of Surgery at the University of Utah School of Medicine. He is a surgeon and investigator with the Huntsman Cancer Institute where he specializes in the complex multidisciplinary care of patients with head and neck cancer.

His clinical practice involves treating patients with cancers of the upper aerodigestive tract (sinuses, oral cavity, pharynx and larynx), neck, thyroid, parathyroid, and salivary glands. In addition, he has a special interest in the treatment of melanoma and advanced skin cancers of the head and neck. He has experience with both traditional open and minimally-invasive procedures, including Transoral Robotic Surgery (TORS). Dr. Monroe believes that the best care comes when a team of specialists works together to create a treatment plan that is tailored to the individual patient. Because of this, he works closely with a team of head and neck cancer specialists, including medical and radiation oncologists, to determine the best possible treatment for each patient.

Dr. Monroe has published numerous articles and book chapters regarding cancers of the head and neck. His research interests include clinical trials for head and neck cancer, risk stratification in thyroid cancer, early identification and treatment of HPV-associated head and neck cancer, and the role of sentinel lymph node biopsy in malignancies of the head and neck.

Dr. Monroe received his medical degree at the University of Missouri—Columbia School of Medicine and completed his residency training in Otolaryngology—Head and Neck Surgery at Oregon Health and Science University (OHSU) in Portland, Oregon. Prior to joining the faculty at the University of Utah, Dr. Monroe completed a 2-year fellowship in Head and Neck Surgical Oncology at the University of Texas M.D. Anderson Cancer Center.

Board Certification and Academic Information

Academic Departments Surgery - Assistant Professor
Academic Divisions Otolaryngology-Head and Neck Surgery
Board Certification American Board of Otolaryngology

Academic Profile

Research Interests

  • Robotic Surgery
  • Thyroid Neoplasms
  • Head and Neck Cancers
  • Human Papillomavirus
  • Clinical Trials
  • Oropharyngeal Neoplasms
  • Sentinel Lymph Node Biopsy

Board Certification and Academic Information

Academic Departments Surgery - Assistant Professor
Academic Divisions Otolaryngology-Head and Neck Surgery
Board Certification American Board of Otolaryngology

Academic Office Locations

Academic Office Phone Number Academic Office Address
(801) 585-7143 School of Medicine
Otolaryngology
30 N Medical Dr
Salt Lake City, UT 84132

Academic Bio

Marcus Monroe, M.D., is an assistant professor in the Division of Otolaryngology—Head and Neck Surgery, Department of Surgery at the University of Utah School of Medicine. He is a surgeon and investigator with the Huntsman Cancer Institute where he specializes in the complex multidisciplinary care of patients with head and neck cancer.

His clinical practice involves treating patients with cancers of the upper aerodigestive tract (sinuses, oral cavity, pharynx and larynx), neck, thyroid, parathyroid, and salivary glands. In addition, he has a special interest in the treatment of melanoma and advanced skin cancers of the head and neck. He has experience with both traditional open and minimally-invasive procedures, including Transoral Robotic Surgery (TORS). Dr. Monroe believes that the best care comes when a team of specialists works together to create a treatment plan that is tailored to the individual patient. Because of this, he works closely with a team of head and neck cancer specialists, including medical and radiation oncologists, to determine the best possible treatment for each patient.

Dr. Monroe has published numerous articles and book chapters regarding cancers of the head and neck. His research interests include clinical trials for head and neck cancer, risk stratification in thyroid cancer, early identification and treatment of HPV-associated head and neck cancer, and the role of sentinel lymph node biopsy in malignancies of the head and neck.

Dr. Monroe received his medical degree at the University of Missouri—Columbia School of Medicine and completed his residency training in Otolaryngology—Head and Neck Surgery at Oregon Health and Science University (OHSU) in Portland, Oregon. Prior to joining the faculty at the University of Utah, Dr. Monroe completed a 2-year fellowship in Head and Neck Surgical Oncology at the University of Texas M.D. Anderson Cancer Center.

Education

Education History

Type School Degree
Fellowship MD Anderson Cancer Center
Head and Neck Surgical Oncology
Fellow
Residency Oregon Health and Science University
Otolaryngology
Resident
Internship Oregon Health and Science University
Surgery
Intern
Professional Medical University of Missouri
Medicine
M.D.
Undergraduate Drury University
Biology and Chemistry Majors, Global Studies Minor
B.A.

Publications

Selected Provider Publications

Journal Article

  1. Monroe MM, Lai SY (2014). Sentinel lymph node biopsy for oral cancer: supporting evidence and recent novel developments. Curr Oncol Rep, 16(5), 385.
  2. Osman AA, Monroe MM, Ortega Alves MV, Patel AA, Katsonis P, Fitzgerald AL, Neskey DM, Frederick MJ, Woo SH, Caulin C, Hsu TK, McDonald TO, Kimmel M, Meyn RE, Lichtarge O, Myers JN (2014). Wee-1 Kinase Inhibition Overcomes Cisplatin Resistance Associated with High Risk TP53 Mutations in Head and Neck Cancer through Mitotic Arrest Followed by Senescence.LID - molcanther.0735.2014 [pii]. Mol Cancer Ther.
  3. Geltzeiler M, Monroe M, Givi B, Vetto J, Andersen P, Gross N (11/1/14). Regional control of head and neck melanoma with selective neck dissection. JAMA Otolaryngol Head Neck Surg, 140(11), 1014-8.
  4. Chard R, Monroe MM, Andersen PE (2013). Hyoid osteoradionecrosis associated with carotid rupture: report of 2 cases. Head Neck, 35(2), E36-8.
  5. Monroe MM, McLean M, Sautter N, Wax MK, Andersen PE, Smith TL, Gross ND (2013). Invasive fungal rhinosinusitis: a 15-year experience with 29 patients. Laryngoscope, 123(7), 1583-7.
  6. Monroe MM, Myers JN, Kupferman ME (2013). Undertreatment of thick head and neck melanomas: an age-based analysis. Ann Surg Oncol, 20(13), 4362-9.
  7. Monroe MM, Gross ND (2012). Evidence-based practice: management of the clinical node-negative neck in early-stage oral cavity squamous cell carcinoma. Otolaryngol Clin North Am, 45(5), 1181-93.
  8. Monroe MM, Anderson EC, Clayburgh DR, Wong MH (2011). Cancer stem cells in head and neck squamous cell carcinoma. J Oncol, 2011, 762780.
  9. Anderson EC, Hessman C, Levin TG, Monroe MM, Wong MH (2011). The role of colorectal cancer stem cells in metastatic disease and therapeutic response. Cancers (Basel), 3(1), 319-39.
  10. Monroe MM, McLean M, Gross ND (2011). Infected tracheal diverticulum presenting as a cervical abscess. Otolaryngol Head Neck Surg, 145(3), 513-4.
  11. Monroe MM, Cannady SB, Ghanem TA, Swide CE, Wax MK (2011). Safety of vasopressor use in head and neck microvascular reconstruction: a prospective observational study. Otolaryngol Head Neck Surg, 144(6), 877-82.
  12. Miller MW, Vetto JT, Monroe MM, Weerasinghe R, Andersen PE, Gross ND (2011). False-negative sentinel lymph node biopsy in head and neck melanoma. Otolaryngol Head Neck Surg, 145(4), 606-11.
  13. Monroe MM, McClelland J, Swide C, Wax MK (2010). Vasopressor use in free tissue transfer surgery. Otolaryngol Head Neck Surg, 142(2), 169-73.
  14. Monroe MM, Sauer DA, Samuels MH, Gross ND (2009). Pathology quiz case 1. Coexistent conventional mucoepidermoid carcinoma of the thyroid (MECT) and papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg, 135(7), 720, 722.

Book Chapter

  1. Monroe MM, Hessman C, Clayburgh D, Bubbers E, Wong ME (2001). Cancer Stem Cells in Solid Organ Malignancies: Mechanisms of Treatment Resistance and Strategies for Therapeutic Targeting. In Stanley Shostak (Ed.), Cancer Stem Cells (ISBN 978-953-307-1454-5).

Clinical Trials

Video & News